| Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis T Didari, S Mozaffari, S Nikfar, M Abdollahi World journal of gastroenterology: WJG 21 (10), 3072, 2015 | 425 | 2015 |
| A systematic review of the safety of probiotics T Didari, S Solki, S Mozaffari, S Nikfar, M Abdollahi Expert opinion on drug safety 13 (2), 227-239, 2014 | 382 | 2014 |
| On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies R Rahimi, S Mozaffari, M Abdollahi Digestive diseases and sciences 54, 471-480, 2009 | 146 | 2009 |
| Implications of melatonin therapy in irritable bowel syndrome: a systematic review S Mozaffari, R Rahimi, M Abdollahi Current pharmaceutical design 16 (33), 3646-3655, 2010 | 82 | 2010 |
| New biologic therapeutics for ulcerative colitis and Crohn's disease S Mozaffari, S Nikfar, AH Abdolghaffari, M Abdollahi Expert opinion on biological therapy 14 (5), 583-600, 2014 | 81 | 2014 |
| Melatonin, a promising supplement in inflammatory bowel disease: a comprehensive review of evidences S Mozaffari, M Abdollahi Current pharmaceutical design 17 (38), 4372-4378, 2011 | 70 | 2011 |
| Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis S Mozaffari, AH Abdolghaffari, S Nikfar, M Abdollahi Human & experimental toxicology 34 (5), 445-459, 2015 | 56 | 2015 |
| Effects of Hypericum perforatum extract on rat irritable bowel syndrome S Mozaffari, H Esmaily, R Rahimi, M Baeeri, Y Sanei, ... Pharmacognosy Magazine 7 (27), 213, 2011 | 51 | 2011 |
| Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis M Moeinian, SF Ghasemi-Niri, S Mozaffari, AH Abdolghaffari, M Baeeri, ... World Journal of Gastroenterology: WJG 20 (31), 10876, 2014 | 39 | 2014 |
| Benefit of Aloe vera and Matricaria recutita mixture in rat irritable bowel syndrome: Combination of antioxidant and spasmolytic effects A Asadi-Shahmirzadi, S Mozaffari, Y Sanei, M Baeeri, R Hajiaghaee, ... Chinese Journal of Integrative Medicine, 1-9, 2012 | 35 | 2012 |
| Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome S Mozaffari, S Nikfar, M Abdollahi Expert opinion on drug metabolism & toxicology 9 (4), 403-421, 2013 | 30 | 2013 |
| Synergistic effect of probiotics, butyrate and L-Carnitine in treatment of IBD M Moeinian, SF Ghasemi-Niri, S Mozaffari, M Abdollahi Journal of medical hypotheses and ideas 7 (2), 50-53, 2013 | 29 | 2013 |
| Phase II drugs under clinical investigation for the treatment of chronic constipation S Mozaffari, T Didari, S Nikfar, M Abdollahi Expert Opinion on Investigational Drugs 23 (11), 1485-1497, 2014 | 25 | 2014 |
| Inflammatory bowel disease therapies discontinued between 2009 and 2014 S Mozaffari, S Nikfar, M Abdollahi Expert Opinion on Investigational Drugs 24 (7), 949-956, 2015 | 21 | 2015 |
| The safety of novel drugs used to treat irritable bowel syndrome S Mozaffari, S Nikfar, M Abdollahi Expert opinion on drug safety 13 (5), 625-638, 2014 | 19 | 2014 |
| The pharmacological management of constipation in patients with Parkinson’s disease: a much-needed relief S Mozaffari, S Nikfar, M Daniali, M Abdollahi Expert Opinion on Pharmacotherapy 21 (6), 701-707, 2020 | 18 | 2020 |
| The mechanisms of positive effects of melatonin in dyslipidemia: a systematic review of animal and human studies S Mozaffari, S Hasani-Ranjbar, M Abdollahi International Journal of Pharmacology 8 (6), 496-509, 2012 | 16 | 2012 |
| Methylnaltrexone bromide for the treatment of opioid-induced constipation S Mozaffari, S Nikfar, M Abdollahi Expert opinion on pharmacotherapy 19 (10), 1127-1135, 2018 | 15 | 2018 |
| Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients S Mozaffari, S Nikfar, M Abdollahi Archives of Medical Science 10 (1), 10-18, 2014 | 14 | 2014 |
| Investigational opioid antagonists for treating opioid-induced bowel dysfunction S Mozaffari, S Nikfar, M Abdollahi Expert Opinion on Investigational Drugs 27 (3), 235-242, 2018 | 13 | 2018 |
Prof Dr Mohammad AbdollahiFaculty of Pharmacy & Pharmaceutical Sciences Research Center (PSRC)(TUMS)Verified email at TUMS.Ac.Ir
